Literature DB >> 477198

The role of the baroreceptor reflex in the cardiovascular effects of propranolol in the conscious spontaneously hypertensive rat.

H A Struyker-Boudier, J F Smits, H Van Essen.   

Abstract

1. The role of baroreceptors in the cardiovascular mechanism of action of DL-propranolol has been studied by comparing the acute effects of subcutaneous injection of 1 and 5 mg/kg (3.3 x 10(-6) and 16.5 x 10(-6) mol/kg) of this drug in conscious baroreceptor-denervated spontaneously hypertensive (SH) rats with those in sham-operated control SH rats. 2. At 5 mg/kg (16.5 x 10(-6) mol/kg) propranolol caused a small, but significant, increase in blood pressure in sham-operated SH rats, whereas both after 1 and 5 mg/kg (3.3 x 10(-6) and 16.5 x 10(-6) mol/kg) immediate hypotension was observed in baroreceptor-denervated animals. 3. Heart rate dropped rapidly after injection of 1 or 5 mg/kg (3.3 x 10(-6) and 16.5 x 10(-6) mol/kg) propranolol both in the baroreceptor-denervated and sham-operated SH rats. Bradycardia was significantly larger in the baroreceptor-denervated animals after an injection of 5 mg/kg (16.5 x 10(-6) mol/kg). 4. It is concluded that the lack of an early hypotensive effect of propranolol in intact animals is caused by an increased baroreceptor reflex activity as a consequence of the fall in cardiac output.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477198     DOI: 10.1042/cs0560163

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  11 in total

1.  Haemodynamic effects of the bacterial quorum sensing signal molecule, N-(3-oxododecanoyl)-L-homoserine lactone, in conscious, normal and endotoxaemic rats.

Authors:  S M Gardiner; S R Chhabra; C Harty; P Williams; D I Pritchard; B W Bycroft; T Bennett
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

2.  Maximal aerobic power and blood pressure in normotensive subjects after acute and chronic administration of metoprolol.

Authors:  M van Baak; W Jennen; F T Verstappen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Propranolol in conscious spontaneously hypertensive rats. I. Cardiovascular effects after subcutaneous and intracerebroventricular administration.

Authors:  J F Smits; H van Essen; H A Struyker-Boudier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

5.  Effect of acute administration of propranolol and atenolol on baroreflex function in normal man.

Authors:  A H Deering; D W Harron; J G Riddell; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Propranolol and atenolol inhibit norepinephrine spillover rate into plasma in conscious spontaneously hypertensive rats.

Authors:  T K Keeton; A M Biediger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

7.  A comparison of the effects of propranolol and oxprenolol on forearm blood flow and skin temperature.

Authors:  M J Vandenburg; C Conlon; J M Ledingham
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

8.  Acute effects of propranolol on the circulation and on oxygen uptake in conscious rats.

Authors:  J M Ledingham; D C Lees
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

9.  Propranolol in conscious spontaneously hypertensive rats. II. Disposition after subcutaneous and intracerebroventricular administration.

Authors:  J M Smits; H A Struyker-Boudier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

10.  Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension.

Authors:  M A van Baak; T L Kho; H Thijssen; K H Rahn
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.